Cargando…

OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

PURPOSE: This review aimed to determine the optimal management of retinal pigment epithelial detachments (PEDs) in neovascular age-related macular degeneration (nAMD) based on review of available evidence in the literature. METHODS: A comprehensive literature review evaluates previous retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanani, Arshad M., Eichenbaum, David, Schlottmann, Patricio G., Tuomi, Lisa, Sarraf, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Retina 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221406/ https://www.ncbi.nlm.nih.gov/pubmed/29697591 http://dx.doi.org/10.1097/IAE.0000000000002195

Ejemplares similares

Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration
por: Selvam, Amrish, et al.
Publicado: (2023)

Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment
por: Zhao, Chun, et al.
Publicado: (2016)

Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment
por: Riazi-Esfahani, Hamid, et al.
Publicado: (2023)

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2011)

Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration
por: Shu, Yiyang, et al.
Publicado: (2023)

Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration
por: Karampelas, Michael, et al.
Publicado: (2020)

Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment
por: Shijo, Taiyo, et al.
Publicado: (2022)

Progression from Type 2 Macular Neovascularization to Fibrovascular Pigment Epithelial Detachment
por: LE, Hoang Mai, et al.
Publicado: (2021)

Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment
por: Nagai, Norihiro, et al.
Publicado: (2016)

Radiomics-Based Prediction of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment
por: Williamson, Ryan Chace, et al.
Publicado: (2023)

Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
por: Samanta, Anindya, et al.
Publicado: (2020)

Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration
por: Khanani, Arshad M
Publicado: (2015)

A hyporeflective space between hyperreflective materials in pigment epithelial detachment and Bruch’s membrane in neovascular age-related macular degeneration
por: Mukai, Ryo, et al.
Publicado: (2014)

Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach
por: Panos, Georgios D., et al.
Publicado: (2015)

Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept
por: Tyagi, Pallavi, et al.
Publicado: (2018)

Retinal pigment epithelium hyperplasia overlying pigment epithelial detachment in age-related macular degeneration can masquerade as neovascularization on optical coherence tomography angiography
por: Chen, Ling, et al.
Publicado: (2018)

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Eyes With Pigment Epithelial Detachments Due to Age-Related Macular Degeneration
por: Sauer, Lydia, et al.
Publicado: (2019)

Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results
por: Callanan, David, et al.
Publicado: (2023)

Evaluation of retinal pigment epithelium changes in serous pigment epithelial detachment in age-related macular degeneration
por: Miura, Masahiro, et al.
Publicado: (2021)

IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER Studies
por: Eichenbaum, David, et al.
Publicado: (2023)

Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration
por: Gonzalez, Andres, et al.
Publicado: (2017)

Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
por: Tran, Thi Ha Chau, et al.
Publicado: (2017)

Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits
por: Kang, Dongwan, et al.
Publicado: (2022)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
por: Khanani, Arshad M, et al.
Publicado: (2019)

Clinical Characteristics of Eyes with Neovascular Age-Related Macular Degeneration and Retinal Pigment Epithelium Tears
por: Nagata, Junya, et al.
Publicado: (2023)

Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
por: Tran, Thi Ha Chau, et al.
Publicado: (2018)

High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
por: Lee, Dong Kyu, et al.
Publicado: (2016)

Full-thickness macular hole with pigment epithelial detachment
por: Narnaware, Shilpi H, et al.
Publicado: (2020)

Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
por: Schütze, Christopher, et al.
Publicado: (2015)

RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Kaiser, Peter K., et al.
Publicado: (2021)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Bacillary Layer Detachment in Neovascular Age-Related Macular Degeneration: Case Series
por: Palmieri, Filomena, et al.
Publicado: (2023)

Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
por: Panos, Georgios D, et al.
Publicado: (2013)

Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration
por: Figurska, Małgorzata
Publicado: (2012)

Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of Neovascularization
por: Yu, Hannah J., et al.
Publicado: (2020)

Detection of pigment epithelial detachment vascularization in age-related macular degeneration using phase-variance OCT angiography
por: McClintic, Scott M, et al.
Publicado: (2015)

Choriocapillaris Flow Deficits and Treatment-Naïve Macular Neovascularization Secondary to Age-Related Macular Degeneration
por: Scharf, Jackson M., et al.
Publicado: (2020)

Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials
por: Singer, Michael, et al.
Publicado: (2020)

Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration
por: Sasaki, Mariko, et al.
Publicado: (2017)

Phacoemulsification Surgery in Eyes with Neovascular Age-Related Macular Degeneration
por: Grixti, Andre, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f7f7kvgtqvnv6vupvi3vq5096p